Article
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).
International journal of cancer - 2 Jan 1994
Fossum B, Gedde-Dahl T, Breivik J, Eriksen J A, Spurkland A, Thorsby E, Gaudernack G
Abstract excerpt
Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p21 ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with...
Topics
- Adenocarcinoma
- Amino Acid Sequence
- Aspartic Acid
- CD4-Positive T-Lymphocytes
- CD8 Antigens
- Cells, Cultured
- Colorectal Neoplasms
- Female
- Gene Amplification
- Genes, ras
- Glycine
